Welcome to our dedicated page for Canopy Growth news (Ticker: CGC), a resource for investors and traders seeking the latest updates and insights on Canopy Growth stock.
Canopy Growth Corporation (CGC) generates a steady flow of news as a cannabis-focused manufacturer with operations spanning medical and adult-use markets, branded products, and vaporization devices. The Canopy Growth news page on Stock Titan aggregates these disclosures so readers can follow how the company’s strategy, financing, and operations evolve over time.
Company news frequently covers financial performance and capital structure. Canopy Growth issues quarterly results releases that discuss cannabis and Storz & Bickel net revenue, segment performance in Canada and international markets, gross margins, operating loss, adjusted EBITDA, and free cash flow, along with commentary on cost management and balance sheet strength. The company also announces financing transactions, such as term loan agreements, prepayments on senior secured debt, convertible debenture exchanges, and at-the-market equity programs.
Another major category of news involves corporate transactions and governance. Canopy Growth has reported entering into an arrangement agreement to acquire MTL Cannabis Corp., detailing consideration, required approvals, and expected strategic benefits. It also publishes results of its annual general and special meetings, including director elections, auditor appointments, share consolidation authority, and advisory votes on executive compensation, as well as updates on board and executive appointments.
Product and market updates are a recurring theme. The company announces launches such as Claybourne Gassers liquid diamonds All-in-One vapes and Claybourne Frosted Flyers infused pre-roll variety packs in Canada, along with expansions of the Spectrum Therapeutics medical portfolio in Australia through new softgel formats. It also highlights operational moves like dedicating the DOJA facility in Kelowna to medical cultivation for Spectrum Therapeutics patients.
Investors and observers who monitor CGC news can use this page to track developments in Canopy Growth’s Canadian adult-use and medical businesses, its international medical operations in Europe and Australia, its indirect exposure to the U.S. THC market through Canopy USA, and its ongoing efforts to manage debt, liquidity, and governance matters. Bookmark this feed to review new press releases, transaction updates, and regulatory communications as they are published.
Canopy Growth (TSX: WEED, NASDAQ: CGC) has launched new holiday-inspired cannabis products. The lineup includes Tweed Cranberry Ginger Ale, a sugar-free cannabis beverage containing 10mg THC, and Tweed Snowtorious 91K flower, an indica strain featuring minty and diesel aromas.
Additional seasonal offerings include 7ACRES Ultra Jack, a sativa-dominant hybrid with citrus and earthy spice notes, and Claybourne Frosted Flyers infused pre-rolls available in various flavors including Blue Dream, Strawberry Cough, Pineapple Express, Grape Gasolina, and Banana OG. Products will be available through legal recreational cannabis channels and the Spectrum Therapeutics online store for medical consumers.
Canopy Growth (TSX: WEED, NASDAQ: CGC) and Acreage Holdings announced that Canopy USA is expected to complete its acquisition of Acreage around December 9, 2024. The acquisition includes both Fixed Shares and Floating Shares of Acreage, subject to closing conditions. Notably, if Canopy Growth's share price on Nasdaq doesn't exceed US$5.00 before closing, Fixed Share holders will receive no consideration. Upon completion, Canopy USA will own 100% of Acreage's outstanding shares. Letters of transmittal for the acquisition will be mailed to registered Acreage shareholders.
Canopy Growth (TSX: WEED, NASDAQ: CGC) has appointed Luc Mongeau as its new CEO, effective January 6, 2025. Mongeau, a current Board member with over 25 years of CPG experience, will succeed David Klein, who announced his planned retirement in August 2024. Mongeau has been involved with the company's board since early 2023, contributing to strategic decisions focused on asset-light expansion and near-term profitability. He previously served as CEO of a leading e-commerce furniture provider and held president roles at Weston Foods and Mars Petcare North America. Klein will transition to a special advisor role until August 31, 2025.
STORZ & BICKEL, a subsidiary of Canopy Growth (TSX: WEED) (NASDAQ: CGC), has won a Gold Medal at the 2024 MarCom Awards for Outstanding Special Event, recognizing their VENTY launch parties. The award celebrates the brand's coast-to-coast product launch events held at Astor Club speakeasies in New York City and Los Angeles. The exclusive events featured product demonstrations by founder Jürgen Bickel, German cuisine, and interactive activities, attracting industry leaders, influencers, and major media outlets including Fast Company, PEOPLE, and Variety.
Canopy Growth (TSX: WEED) (NASDAQ: CGC) has announced the launch of Claybourne's Frosted Flyers Infused Pre-Rolls in Canada through an exclusive licensing agreement. The product will be available in five varieties: Blue Dream, Strawberry Cough, Pineapple Express, Grape Gasolina, and Banana OG, featuring 42-48% THC content. The launch targets the rapidly growing pre-roll market in Canada, which has grown 94% since 2022, with infused pre-rolls representing 9.6% of the total recreational market. The products feature diamond frosting, liquid diamond infusion, terpene enhancement, and premium indoor full nug flower.
Canopy Growth (TSX: WEED, Nasdaq: CGC) reported Q2 FY2025 financial results with mixed performance. Net revenue decreased 9% year-over-year to $63.0MM, though excluding divested businesses, it grew 3%. Storz & Bickel showed strong growth with revenue up 32% to $16MM. Medical cannabis revenue increased in both Canada (16%) and international markets (12%). The company reduced its Adjusted EBITDA loss by 54% to $6MM and improved free cash flow by 16%. Gross margin increased to 35%, up 100 basis points from last year. The cash position strengthened to $231MM, up from $195MM in the previous quarter.
Canopy Growth (TSX: WEED) (NASDAQ: CGC) has announced it will release its second quarter fiscal 2025 financial results before market open on November 8, 2024. The results will cover the period ended September 30, 2024. Following the release, the company will host an audio webcast at 10 AM Eastern Time featuring CEO David Klein and CFO Judy Hong. The webcast will be available live and accessible for replay until February 6, 2025.
Canopy Growth (TSX: WEED) (NASDAQ: CGC) has made an early prepayment of US$100 million on its senior secured term loan at a discounted price of US$97.5 million. This move will result in annualized interest expense savings of approximately US$14 million and extends the loan's maturity date to December 18, 2026. The company has the option to make an additional US$100 million prepayment by March 31, 2025, which would further extend the maturity to September 18, 2027.
This action is part of Canopy Growth's strategy to reduce leverage, improve its balance sheet, and demonstrate fiscal discipline. CFO Judy Hong stated that this prepayment reflects the company's commitment to reducing cash burn and strengthening its capital structure, enabling investment in growth areas and long-term value creation for shareholders.
Canopy Growth (TSX: WEED, NASDAQ: CGC) has confirmed that Canopy USA has completed its acquisition of Wana, including Wana Wellness, The CIMA Group, and Mountain High Products. This follows Canopy USA's acquisition of approximately 75% of Jetty shares in June 2024. The move aligns with Canopy USA's strategy to establish a leading brand-focused cannabis company in the U.S.
Wana recently launched Wanderous™, a direct-to-consumer marketplace offering hemp-derived products, including Delta-9-THC and CBD gummies from various brands. Wana also introduced a new line of infused sparkling beverages. The acquisition is expected to unlock new growth opportunities in state-legal markets and through hemp-derived products across the U.S.
Canopy USA anticipates realizing significant financial benefits, including revenue growth and cost synergies, from the acquisitions of Wana, Jetty, and the contemplated acquisition of Acreage Holdings.
Canopy Growth (TSX: WEED) (NASDAQ: CGC) announced the voting results from its annual general meeting held on September 24, 2024. All matters put forward for shareholder consideration were approved. The election of directors saw all nominees elected with votes FOR ranging from 87.26% to 89.23%. Shareholders also approved the appointment of PKF O'Connor Davies, LLP as auditors for the fiscal year ending March 31, 2025, and authorized the board to fix their remuneration. Additionally, an advisory resolution on executive compensation was approved. Detailed voting results will be available on SEDAR+ and EDGAR.